Efforia
New York, 10003, United States
Location status: Recruiting
NCT Number: NCT07281963
This study evaluates the Chilipad Dock Pro Bed Cooling System and Sleep Tracker, examining how bed temperature influences sleep quality and overall well-being.
Interested in participating?
Request InfoAll sexes
Interventional
Not applicable
New York, 10003, United States
Location status: Recruiting
This remotely administered decentralized trial is designed to rigorously evaluate the impact of the Chilipad Dock Pro Bed Cooling System on sleep quality and overall well-being. In a world where optimal sleep remains elusive for many, this study seeks to provide evidence-based insights into how temperature regulation can significantly affect restful nights. Leveraging the potential of the Chilipad Dock Pro Bed Cooling System, which offers personalized temperature settings aimed at enhancing the sleep environment, this research focuses on quantifying its effectiveness through scientifically validated metrics.
Participants in this study will engage in a comprehensive assessment process, utilizing the PROMIS Sleep Disturbance Scale, Well-being Survey, and SF-36 as primary tools for measuring outcomes. By collecting data remotely from participants in their natural sleep settings, this trial aims to offer a real-world evaluation of the system's capability to improve sleep quality. From baseline to endpoint, the study will monitor changes in sleep disturbance, overall well-being, and health-related quality of life, providing a robust dataset for analysis.
The overarching objective of this research is to empower participants with concrete, science-backed data on the impact of the Chilipad Dock Pro Bed Cooling System on their sleep and well-being. By the conclusion of the study, participants will have access to measurable insights into how the system has influenced their sleep patterns and quality of life, thereby aiding in informed decision-making for enhanced health outcomes.
Furthermore, this study stands to significantly contribute to the broader scientific and healthcare communities by establishing a clear link between temperature regulation during sleep and sleep quality improvements. In addressing the gap between anecdotal evidence and scientific validation, the findings from this research are anticipated to underscore the importance of sleep environment optimization. By demonstrating the efficacy of the Chilipad Dock Pro Bed Cooling System through significant changes in validated measures of sleep and well-being, this study could pave the way for revolutionary approaches in sleep health management, acknowledging the limitations posed by individual sleep needs variability and external environmental factors.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The Chilipad Dock Pro Bundle is an advanced sleep system designed to optimize sleep by dynamically adjusting the bed's surface temperature. It consists of a thermoregulated mattress pad and a Dock Pro control unit that actively circulates water through the pad, allowing users to customize the temperature between 55°F and 115°F. The system offers both single and dual control, making it ideal for individual or shared use. Equipped with AI-driven features, the Dock Pro can monitor sleep patterns and environmental factors to make real-time adjustments, ensuring optimal sleep conditions throughout the night. This intelligent temperature management system is only enhanced when paired with the optional Sleepme Tracker, creating a personalized sleep experience.
Time frame: Change from baseline (Day 1-3) in PROMIS Sleep Disturbance Scale at 4 weeks after the start of the intervention (Day 27-33)
The PROMIS Sleep Disturbance Scale is a validated and widely used assessment tool developed as part of the Patient-Reported Outcomes Measurement Information System (PROMIS) initiative. It is designed to measure the severity of sleep disturbances and disruptions experienced by individuals. This scale includes a range of questions that assess the frequency and impact of various sleep-related issues, such as difficulty falling asleep, nighttime awakenings, and restless sleep. Healthcare professionals and researchers rely on this scale to better understand and quantify sleep problems in patients, enabling them to tailor interventions and treatment strategies to address sleep-related concerns effectively.
Time frame: Change from baseline (Day 1-3) in Well-being Survey at 4 weeks after the start of the intervention (Day 27-33)
Please answer the following questions to assess your well-being.
Time frame: Change from baseline (Day 1) in SF-36 at 4 weeks after the start of the intervention (Day 29-31)
The SF-36, or Short Form 36, is a widely used health-related quality of life questionnaire that consists of 36 questions designed to assess a person's physical and mental well-being. It measures various aspects of an individual's health, including physical functioning, role limitations due to physical and emotional problems, social functioning, mental health, energy and vitality, pain, and general health perceptions. The SF-36 provides a comprehensive overview of a person's health status and is frequently used in clinical research, healthcare assessments, and population health studies. Its versatility and ability to assess multiple dimensions of health make it a valuable tool for evaluating the impact of medical interventions and health-related interventions.
Contact information is provided by the study sponsor or research team.
Efforia, Inc
Industry
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01778504
Autism Spectrum Disorder, Autistic Disorder
Bethesda, Maryland, United States
View Trial DetailsNCT07489417
Blood Pressure, Sleep
Columbia, Missouri, United States
View Trial DetailsNCT07729930
Arthralgia, Blood Pressure and Augmentation Index
Loughborough, United Kingdom
View Trial DetailsNCT07411222
Behavior, Bipolar Disorder
Bolu, Turkey (Türkiye)
View Trial Details